Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease by unknown
Brief  Definitive Report 
Cytotoxic T  Cells Deficient in Both Functional  Fas Ligand 
and Perforin Show Residual Cytolytic Activity yet Lose Their 
Capacity to Induce Lethal Acute Graft-Versus-Host Disease 
By MichelY. Braun,* Bente Lowin,~ Lars Frenchfl Hans Acha-Orbea,* 
and Ji.irg Tschopp~ 
From the *Ludwig Institute  for Cancer Research and :~Institute of Biochemistry, University of 
Lausanne, CH-1066 Epalinges; and ~Department of Dermatology and Epithelium Network, 
University of Geneva Medical School, CH- 1211 Geneva 4, Switzerland 
Summary 
Graft-versus-host disease  (GVHD)  is  the  main  complication  after  allogeneic  bone  marrow 
transplantation. Although the tissue damage and subsequent patient mortality are clearly depen- 
dent on T  lymphocytes present in the grafted inoculum, the lethal effector molecules are un- 
known.  Here, we show that acute lethal GVHD, induced by the transfer of splenocytes from 
C57BL/6 mice into sensitive BALB/c recipients, is dependent on both perforin and Fas ligand 
(FasL)-mediated lytic pathways.  When  spleen  cells  from mutant  mice lacking both  effector 
molecules were transferred to sublethally irradiated  allogeneic recipients,  mice survived. De- 
layed mortality was observed with grafted cells deficient in only one lytic mediator. In contrast, 
protection from lethal acute GVHD in resistant mice was exclusively pefforin dependent. Per- 
forin-FasL-deficient T  cells  failed to lyse most target cells  in vitro.  However, they still  effi- 
ciently killed tumor necrosis factor oe-sensitive fibroblasts, demonstrating that cytotoxic T  cells 
possess a third lytic pathway. 
C 
TL  are  important  cytolytic  effector cells  of the  im- 
mune  defense system against viruses and  tumors  (1). 
CD4 + and CD8 + CTL are also involved in autoimmunity 
and transplant rejection.  The recent development of mice 
in which the gene for perforin is disrupted  (2-4)  has pro- 
vided evidence for the existence of two separate lytic path- 
ways: first,  the  formation of membrane pores by perforin 
released from intracellular stores  (5)  followed by the pro- 
teolytic action  of granzymes that are coreleased with per- 
forin and that induce  apoptosis in  the  target cell  (6);  sec- 
ond,  the  triggering of the  Fas  (Apo-1)-induced  apoptotic 
pathway by Fas ligand (FasL)  exposed on the CTL surface 
(7). At present it appears that the two pathways account for 
all  cytolytic  activity of CTL.  However,  only a  restricted 
number of target cells  could be analyzed,  since  functional 
inactivation  of the  Fas pathway is  achieved by the  use of 
target cells from lpr mice, which express little or no Fas (8). 
Thus, it cannot be excluded that other lytic molecules such 
as TNF-r  which is detected on the surface of activated T 
lymphocytes  (9),  contribute  to  the  cytotoxicity  of CTU 
For this reason we generated mice in which both perforin 
and FasL are nonfunctional, by crossing perforin knock-out 
mice  with gld  mice,  which  bear  a  mutation  in  the  FasL 
gene leading to its functional inactivation  (10).  Our study 
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now shows that CTL derived from these mice still display 
lytic activity on transformed fibroblast cell lines. 
These double-mutant mice also offered the unique pos- 
sibility to evaluate the role ofperforin and FasL in GVHD. 
GVHD continues to be a major complication after alloge- 
neic  bone  marrow transplantation  (BMT)  (11).  An  acute 
lethal form of GVHD is caused by activation of the host- 
reactive donor effector T  cells  (12).  The major organs af- 
fected in GVHD are skin, liver, intestine, and lymphoid tis- 
sues (13,  14),  and symptoms range from varying degrees of 
erythroderma, wasting, diarrhea, splenomegaly, and lymph- 
adenopathy to death (14).  The lytic mechanisms leading to 
lesion formation are only poorly understood and might in- 
volve, for acute GVHD, direct interactions between donor 
CTL  and  host  target  cells,  or more  indirect  mechanisms 
mediated by interleukins released by the donor T  cells (15). 
We therefore explored the possibility that perforin or FasL 
may  play  a  role  in  the  etiology  of the  lesions  seen  in 
GVHD. 
Materials  and Methods 
Animals.  Pefforin-deficient  (P-/-) gld/gld mice were gener- 
ated by crossing pefforin knock-out (C57BL/6  ￿  129)F3 mice 
(16) with  C57BL/6 gld/gld  mice  (The Jackson  Laboratory,  Bar 
Harbor, ME) and by subsequent intercrossing of heterozygous  F1 
animals. To detect  the FasL-gld mutation, mouse tail DNA was 
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GTCCATCCCTCTG-3'  and 5'-ATATTCCTGGTGCCCAT- 
GAT-3'. The amplification product was sequenced to detect the 
gld homozygotes (17,  18).  Mice were screened for the defective 
perforin gene as described (16) . 
Flow Cytometric Analysis.  Splenocytes from 6- and 16-wk-old 
mice were isolated and freed from red blood cells by 15-min in- 
cubation in an ice cold buffer containing 13  mM sodium bicar- 
bonate,  156 m/vl ammonium chloride, and 127 I~M EDTA, and 
then resuspended in PBS supplemented with 5% FCS and 0.02% 
NaN  3. Splenocytes were stained with Tri-Color-conjugated anti- 
B220  antibodies and HTC-labeled anti-CD3  antibodies (CAL- 
TAG Laboratories, South San Francisco, CA) and analyzed using 
a  FACScan  |  flow cytometer (Becton  Dickinson  Immunocyto- 
metric Systems, Mountain View, CA) using the Lysis II software. 
Cytolytic Assays.  Alloreactive cytotoxic T  lymphocytes were 
generated in  a  5-d mixed lymphocyte culture  (16).  Responder 
spleen cells (2.5  ￿  106/m1-1)  were from adult 6-wk-old mice de- 
ficient for pefforin, functional FasL  (gld/gld), or both.  All mice 
were of H-2  b haplotype. Stimulators were irradiated spleen cells 
(2.5  ￿  106/ml -l, 3,000 rad) from either DBA/2 mice (H-2  d) or 
C3H  (H-2  k) mice. Target ceils were activated splenocytes from 
DBA/2  mice  stimulated with  ConA  (4  pLg/m1-1) for  3  d  (2), 
A20.2J  B  cell  lymphomas  (H-2a),  WEHI  164  fibrosarcomas 
(H-2a), and L929 (H-2  k) fibrosarcomas, all obtained from Ameri- 
can  Type Culture  Collection (Rockviile, MD).  Mouse  embry- 
onic fibroblasts (MEF) were isolated from  12  to  14-d-old C3H 
embryos as described (2). Cytotoxicity on targets of hematopoi- 
etic origin was assayed after 4 h for SlCr release and DNA degra- 
dation (16). Adherent target cells were labeled with SiCr for 12 h 
as described elsewhere (16), and SlCr release was determined after 
a  20-h  incubation.  Recombinant  mouse  TNF-ot  was  obtained 
from Dr. J. Browning, Biogen (Boston, MA). 
Induction of G VHD.  6-wk-old female recipients were given a 
sublethal dose of Co irradiation (5 Gy; 1.2 Gy/min). Within 1 h, 
40  ￿  106  of spleen cells isolated from female allogeneic donors 
were  injected through  the  tail vein.  Animals used in  the study 
were BALB/c, C57BL/6, 129, (C57BL/6 ￿  129)F1,  (C57BL/6 ￿ 
129)P -/-,  C57BL/6 gld/gld,  and  (C57BL/6  X  129)p-l-girl~girl 
mice. R.ate of survival was recorded daily. Mice with the gld/gld 
mutation were used at 5-6 wk of age. A minimum of four recip- 
ient animals were used in each experimental group. 
Results  and Discussion 
Mutant  mice deficient for both  perforin and  functional 
FasL were generated by intercrossing P-/-  mice  (16)  with 
gld/gld  mice (19) lacking functional FasL (17,  18). Animals 
homozygous  for  both  nonfunctional  genes  were  viable. 
Flow immunocytometric analysis of the spleen cell popula- 
tion of young animals (6 wk old) showed a phenotype sim- 
ilar to that observed in normal mice (Fig. 1). With progres- 
sive  age  (from  8  wk  old  onward),  however,  these  mice 
developed a  more  severe lymphadenopathy  than  the  one 
previously described in gld/gld mice (19). Lymphoid organs 
of P-/-gld/gld  mice  were  massively enlarged.  Spleens  de- 
rived from  16-wk-old  P-/-gld/gld  mice  were  on  average 
seven  times  heavier  than  those  from  age-matched  P-/- 
mice,  or 3.5  times  heavier than  the  corresponding organs 
from gld/gld mice (Lowin, B., and J. Tschopp, unpublished 
results). A  predominant CD3+B220+CD4-CD8 -  popula- 
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Figure 1.  Lymphocyte populations in the spleen of P-/-, girl~girl, and 
P-/-gld/gld mice. Spleen cells were analyzed for the expression of CD3 
and B220 by flow cytometry. Normal development of splenocytes de- 
rived from 6-wk-old P-/-gld/gld nfice and accumulation of CD3 +B220  + 
cells in splenocytes from 16-wk-old  P-/-gld/gld and gld/gld mice. The 
CD3+B220 + population was CD4-CD8- (data not shown). 
tion accumulated (Fig. 1) that resembled the T  cell popula- 
tion found in gld/gld mice (19). This phenotype represented 
~50%  of all splenocytes in  16-wk-old double-mutant mice 
(Fig.  1).  A  high proportion of T  cells in P-/-gld/gld  mice 
expressed  activation  markers  such  as  CD69  (data  not 
shown),  pointing  to  a  chronic  activation  of the  immune 
system. Most mice died at an age of 4-5 mo. 
T  cells from  double  mutant  animals  exhibited  no  lytic 
activity on  several target cells tested. Whereas  alloreactive 
T  cells  (H-2  b)  derived  from  6-wk-old  P-/-  and  gld/gld 
mice  were  able  to  kill  ConA-stimulated  allogeneic  lym- 
phoid  cells  (H-2  d)  as  well  as  the  B  cell  lymphoma  A20, 
splenocytes from  P-/-gld/gld  mice were  completely inac- 
tive (Fig. 2). The differences in cytotoxicity are unlikely to 
be  caused  by large  differences  in  the  allogeneic reaction, 
since  IFN-~/  concentration  in  the  supernatants  of the  re- 
spective  mixed  leukocyte  reactions  was  similar  (3,000  + 
500  U/nil supematant).  These data thus confirm that per- 
forin-  and  Fas-dependent pathways  are  responsible  for  all 
detectable  lytic  activity against  lymphoid  targets  in  short 
term  cytotoxicity assays  (2-4,  20).  Cytolytic activity was 
also  tested  in  long-term  (20  h)  cytotoxicity assays against 
nonhematopoietic  target  cells,  that  is,  the  fibrosarcoma 
WEHI-164  (H-2a),  L929  (H-2k),  and  MEF  (H-2a).  As 
shown in Fig. 3  a, MEF cells were not lysed in the absence 
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Figure  2.  Killing of hematopoietic target  cells  by  P-/-gld/gld  CTL. 
CTL activity ofMHC alloantigen-specific T  cells (H-2  b anti-H-2  a) from 
normal mice (triangles), P-/- mice (squares), gld/gld mice (drcles) and P-/-gld/ 
~ld mice (diamonds)  was tested on ConA-activated spleen cells  [filled sym- 
bols) and on the B  cell lymphoma A20  (open  symbols).  The lytic activity 
was determined in both standard S:Cr release (left) and DNA degradation 
(right) assays. 
of both perforin and functional FasL, but surprisingly, kill- 
ing of WEHI-164 and L929 was not significantly affected. 
The sensitivity pattern of target cells correlated with their 
respective  susceptibility to  TNF-~t  (Fig.  3  b),  a  cytokine 
mainly secreted by activated macrophages,  NK cells,  and 
some subpopularions oft  cells (9). TNF-tx has been shown 
in vitro to exhibit slow cytolytic activity (21), and in vivo, 
the production of TNF-ot has been correlated with tissue 
injuries occurring in many immunopathological situations 
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Figure  3.  Killing ofnonhematopoietic target cells by P-/-gld/gld  CTL. 
(a)  As in  Fig. 2,  alloantigen-specific T  cells  (H-26  anti-H-2  '~ and H-2  b 
anti-H-2  k)  were  generated  in  a  5-d  mixed lymphocyte culture  (P-/- 
[squares], gld/gld  [circles], P-/-gld/gld  [diamonds]),  and  their lytic activity 
was tested on the fibrosarcomas WEHI-164 (H-2  d, open symbols)  and L929 
(H-2  k, filled  symbols,  left),  and on primary MEF (H-2  k,  right).  (b) TNF-ot 
sensitivity of  the same target cells as in (a) was determined in a 20-h cyto- 
toxicity test in the presence of increasing amounts of recombinant mouse 
TNF-ot (WEHI-164 [squares], L929 [circles], MEF [triangles]). 
(22-24).  This suggests  that TNF-ot-mediated cytotoxicity 
is at least in part responsible for the lyric activity remaining 
in P-/-  and FasL-deficient animals.  Other cytolyric mole- 
cules, such as lymphotoxins (9) or NK lysins (25), may also 
contribute  to  the  residual  cytotoxicity, since  neutralizing 
anti-TNF-ot antibodies only partially inhibited this activity 
(10-30% specific reduction). 
GVHD  remains the main complication after allogeneic 
BMT. Since the effector molecules leading to lesion forma- 
tion are  only poorly understood, we investigated the role 
of perforin- and Fas-mediated cytolytic pathways in a mu- 
rine model of acute lethal GVHD whereby donor spleno- 
cytes from C57BL/6 or 129  (H-2  b) mice are injected into 
sublethally irradiated allogeneic BALB/c (H-2  a) mice (26). 
Fig.  4  a  shows  that  all  BALB/c  recipients  injected with 
C57BL/6 or 129 spleen cells  (40  X  106)  died within 7 d, 
whereas injection of spleen cells from P-/-  mice or func- 
tional FasL-deficient mice delayed the onset of the disease 
(survival mean 17 and 24 d, respectively). In contrast, mice 
given cells from P-/-gld/gld animals were  unaffected and 
survived (survival mean >50 d). 
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Figure 4.  (a) Both perforin- and Fas-mediated cytotoxic pathways par- 
ticipate in lethal acute GVHD. Spleen cells from normal C57BL/6,  129, 
(C57BL/6  X  129)F1  donors,  P-/-  and  functional FasL-deficient mice 
(gld/gld)  were  transferred into sublethally irradiated BALB/c recipients, 
and the rate of mortality of the recipients was recorded. Animals given 
only  sublethal irradiation  survived indefinitely (survival  mean  >50  d). 
Data are representative of three experiments with at least four mice per 
group (including control donors) per experiment. (b) Resistance to lethal 
acute GVHD is perforin dependent. Normal BALB/c spleen cells were 
injected into sublethally irradiated normal [C57BL/6,  129,  (C57BL/6  X 
129)F1],  P-/-, orgld/gld  recipients. 
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7  d  when  inoculated  with  normal  C57BL/6  spleen  cells 
(Fig.  4  a), irradiated  C57BL/6  (or 129)  recipients  injected 
with the same number of BALB/c spleen cells survive and 
show  no  signs  of illness  (Fig.  4  b)  (26,  27).  Whether  this 
difference of sensitivity reflects the ability of the  C57BL/6 
mice  to  eliminate  potentially  alloreactive  BALB/c  CTL 
from the graft or is caused by a low frequency of BALB/c 
anti-C57BL/6  CTL  precursors  in  BALB/c  splenocytes  is 
not  known.  We  therefore  transferred  normal  BALB/c 
spleen  cells into  sublethally  irradiated  C57BL/6  recipients 
deficient  for  either  perforin  or  functional  FasL.  BALB/c 
splenocytes failed to induce any symptoms of lethal GVHD 
in  nomaal  and  gld/gld  recipients  (Fig.  4  b).  In  contrast, 
C57BL/6  recipients  lacking  functional  perforin  became 
susceptible to BALB/c splenocytes and died within 7-8  d. 
Thus,  normal  sublethally  irradiated  C57BL/6  recipients 
contain  radioresistant  cells that are able to suppress the  ef- 
fector  function  of BALB/c  splenocytes  solely  through  a 
pefforin-dependent pathway. The cell population responsi- 
ble  for  this  inhibition  might  include  host  antidonor  ra- 
dioresistant  CTL,  NK cells,  or natural  suppressor  cells ap- 
pearing after total body irradiation  (27, 28). 
In the murine model of lethal GVHD studied here, both 
perforin and FasL appear to play a crucial role in mortality. 
Other  lytic  effector  molecules  still  detected  in  perforin- 
FasL-deficient  lymphocytes contribute  little,  although  our 
study cannot exclude the involvement of TNF-0~ or other 
cytokines in milder forms of GVHD, as suggested by others 
(15,  23).  In vivo, pefforin's implication in the clearance of 
lymphocytic cboriomeningitis  virus infection  and fibrosar- 
coma tumor cells is well established (4, 29), whereas the Fas 
system was shown to be involved in the elimination of acti- 
vated lymphocytes in the periphery (7, 30). This study now 
demonstrates  that FasL also participates in pathological  tis- 
sue damage during GVHD, in agreement with the observa- 
tion  that  injection  of anti-Fas  antibodies  into  adult  mice 
can  cause rapid  death  due  to liver failure  (31).  In view of 
the  massive upregulation  of FasL in  functional  Fas  recep- 
tor-lacking  Ipr (lymphoproliferation)  mice (32, 33),  the se- 
vere wasting  syndrome  (GVHD)  observed when  lpr bone 
marrow-derived cells are adoptively transferred into a syn- 
geneic wild-type recipient  (34)  may also be explained. Tis- 
sues  attacked  in  FasL-mediated  GVHD  probably  include 
those  that  abundantly  express  Fas,  such  as  liver,  lung,  or 
heart, whereas pefforin, with no requirement for a specific 
receptor (35), may eventually destroy any organ. 
Although  both  perforin-  and  Fas-dependent  pathways 
are responsible for the mortality caused by acute GVHD in 
BALB/c  mice,  perforin-mediated  cytotoxicity  appears  to 
be the only pathway required for the rejection ofallogeneic 
spleen cells.  P-/-  mice still reject heart allografts (36),  and 
thus  effector mechanisms  used  to reject  tissues  and  organs 
of different origin seem to differ. 
GVHD remains a major barrier to a wider application of 
allogeneic BMT for a variety of diseases. Provided that the 
active role of FasL and pefforin in the progression of acute 
GVHD  can be  illustrated  in  humans,  the  development  of 
therapeutic strategies aimed at controlling the two cytolytic 
pathways during BMT  may be an approach for decreasing 
the risk of GVHD. 
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